prospect
enrol
patient
year
age
present
cap
hospit
hospit
universidad
de
chile
hospit
lucio
santiago
chile
februari
decemb
cover
respiratori
viral
season
studi
approv
univers
institut
review
board
adult
provid
inform
consent
particip
studi
cap
defin
presenc
acut
respiratori
symptom
week
chest
radiograph
display
new
pulmonari
infiltr
exclus
criteria
includ
immunodefici
condit
ie
human
immunodefici
viru
activ
treatment
cancer
organ
transplant
immunosuppress
therapi
hospit
within
day
preced
enrol
clinic
inform
admiss
hospit
cours
extract
hospit
chart
patient
enter
comput
databas
patient
sever
assess
first
hour
enrol
accord
pneumonia
sever
index
describ
fine
et
al
addit
routin
laboratori
test
complet
blood
cell
count
biochemistri
panel
oxygen
satur
enrol
person
collect
urin
blood
bacteri
cultur
respiratori
secret
viral
bacteri
diagnost
acut
serum
sampl
serolog
sputum
nasopharyng
aspir
bronchoalveolar
lavag
fluid
obtain
depend
condit
patient
immedi
transport
ice
laboratori
aliquot
differ
diagnost
assay
prepar
store
later
test
particip
contact
week
clinic
followup
convalesc
sera
collect
sera
process
immedi
store
respiratori
secret
inocul
onto
cell
vi
ifa
cultur
perform
sampl
describ
elsewher
use
monoclon
antibodi
kindli
provid
l
anderson
center
diseas
control
prevent
atlanta
georgia
commerci
conjug
antisera
sigma
realtim
reversetranscript
rtrt
pcr
sampl
treat
guanidinium
thiocyanatephenolchloroform
method
rna
extract
complementari
dna
cdna
synthes
rna
sampl
f
gene
primer
hour
follow
minut
perkinelm
gene
amppcr
system
fragment
n
gene
amplifi
rtpcr
primer
master
sybr
green
roch
cdna
reaction
carri
minut
sequenti
cycl
second
second
second
lightcycl
instrument
roch
neg
water
posit
control
rna
rsv
work
pool
includ
assay
heatinactiv
sera
test
microneutr
assay
rsvatraci
viru
measur
rsva
rsvbspecif
neutral
antibodi
describ
previous
vi
mdck
cell
ifa
use
detect
adenoviru
influenza
b
virus
flu
parainfluenza
virus
type
describ
previous
human
metapneumoviru
hmpv
coronaviru
picornaviru
pv
detect
rtrtpcr
amplifi
fragment
n
gene
conserv
region
replicas
gene
conserv
region
respect
describ
previous
pair
fragment
pv
purifi
sequenc
use
kit
abi
prism
dye
termin
cycl
sequenc
readi
reaction
autom
sequenc
abi
model
appli
biosystem
serum
antibodi
hmpv
subgroup
b
detect
microneutr
enzymelink
immunosorb
assay
hemagglutin
inhibit
test
influenza
antibodi
perform
describ
previous
rsv
flu
hmpv
infect
defin
rise
antibodi
titer
convalesc
acut
pair
sera
sputum
sampl
display
leukocyt
epitheli
cell
per
power
field
gram
stain
process
accord
standard
techniqu
legionella
isol
sampl
inocul
onto
buffer
charcoal
yeast
extract
gvpc
media
oxoid
incub
day
urinari
antigen
streptococcuspneumonia
legionella
detect
use
immunochromatograph
test
binax
portland
oregon
chlamydia
pneumonia
detect
use
primer
hl
hr
nest
pcr
amplifi
chromosom
dna
segment
psti
pcr
mycoplasma
pneumonia
legionella
perform
describ
previous
serum
antibodi
c
pneumonia
pneumonia
detect
commerci
ifa
kit
serofia
sayvon
israel
zeu
respect
immunoglobulin
igm
rise
immunoglobulin
g
igg
titer
pair
sera
regard
acut
infect
legionella
serolog
perform
use
latex
test
kit
legionella
oxoid
analysi
perform
use
ztest
categor
data
test
mannwhitney
ranksum
test
continu
variabl
geometr
mean
serumneutr
antibodi
titer
gmst
logist
regress
use
determin
whether
rsva
rsvb
gmst
associ
likelihood
rsv
infect
hospit
odd
ratio
or
confid
interv
ci
determin
rsva
rsvb
gmst
level
signific
set
p
data
analyz
use
sigmastat
softwar
total
adult
cap
enrol
admit
hospit
requir
intens
care
unit
icu
support
outpati
die
hospit
admiss
day
discharg
studi
popul
consist
women
men
mean
age
year
rang
year
year
old
year
old
year
old
one
predefin
comorbid
identifi
patient
cardiac
diseas
preval
comorbid
one
hundr
twentynin
adult
smoker
adult
receiv
antimicrobi
therapi
hospit
admiss
respiratori
failur
fine
score
determin
adult
cap
class
class
class
class
class
overal
rsv
infect
establish
adult
cap
characterist
patient
summar
tabl
signific
differ
demograph
clinic
characterist
tabl
routin
laboratori
test
observ
adult
without
rsvrelat
cap
likewis
clinic
outcom
similar
group
tabl
except
adult
infect
rsv
compris
higher
proport
case
diseas
progress
chest
radiograph
compar
noninfect
adult
vs
p
ifa
cell
cultur
identifi
rsv
infect
techniqu
rsv
detect
rtrtpcr
adult
wherea
serolog
diagnos
rsv
infect
adult
pair
sera
sensit
rtrtpcr
microneutr
assay
similar
p
significantli
better
ifa
vi
p
among
adult
infect
rsv
detect
convent
methodolog
ifa
cell
cultur
rtrtpcr
rise
rsvspecif
serumneutr
antibodi
titer
occur
rsvinfect
adult
pair
sera
rsva
assay
rsvb
assay
microneutr
assay
pair
serolog
studi
avail
adult
rsvposit
rtrtpcr
result
concord
case
tabl
compar
case
detect
rtrtpcr
patient
experienc
rsv
seroconvers
clinic
characterist
laboratori
paramet
similar
durat
symptom
admiss
also
similar
median
vs
day
p
serum
sampl
taken
day
median
vs
day
begin
symptom
respect
presenc
comorbid
less
common
seroconvert
vs
p
compar
rtrtpcr
microneutr
sensit
serolog
gave
higher
yield
rtrt
pcr
p
patient
without
comorbid
vs
major
rsvrelat
cap
occur
may
august
tabl
figur
significantli
fewer
nonrsvrel
cap
case
occur
may
august
adult
treat
cap
month
may
august
like
rsvrelat
cap
compar
month
rel
risk
ci
adult
cap
neutral
antibodi
rsva
rsvb
acut
serum
sampl
obtain
day
admiss
case
first
week
ill
onset
rang
day
median
day
gmst
rsva
rsvb
acut
ill
phase
significantli
lower
adult
rsv
infect
compar
nonrsvinfect
adult
vs
vs
rsva
rsvb
respect
p
signific
differ
also
remain
analysi
limit
case
pair
sera
tabl
logist
regress
analysi
detect
protect
role
rsvspecif
serumneutr
antibodi
rsv
infect
rsva
ci
p
rsvb
ci
p
icu
admiss
rsva
ci
p
rsvb
ci
p
previous
report
minim
protect
threshold
titer
neutral
antibodi
rsv
b
respect
rsvrelat
hospit
use
evalu
risk
rsvrelat
cap
significantli
higher
proport
adult
rsvrelat
cap
rsvaspecif
gmst
compar
nonrsvrel
cap
vs
p
likewis
significantli
higher
proport
adult
rsvrelat
cap
rsvb
gmst
compar
nonrsvrel
cap
vs
p
respiratori
secret
urin
obtain
patient
detect
virus
bacteria
blood
cultur
perform
case
picornaviru
coronavirus
studi
subset
case
august
decemb
case
rsvrelat
cap
frequent
anoth
agent
identifi
respiratori
virus
bacteria
virus
bacteria
case
interestingli
patient
differ
agent
identifi
adult
rsvrelat
cap
virus
identifi
addit
pneumonia
tabl
prospect
studi
cap
adult
use
comprehens
diagnost
approach
identifi
etiolog
agent
santiago
chile
relev
proport
adult
cap
hospit
die
indic
find
bias
toward
spectrum
sever
diseas
rsv
identifi
patient
rsv
detect
popul
vari
depend
mainli
diagnost
method
use
high
frequenc
found
explain
applic
sensit
molecular
diagnost
method
rsvspecif
serolog
rtrtpcr
show
significantli
better
diagnost
perform
ifa
viral
cultur
method
prefer
diagnost
test
identifi
rsv
adult
cap
expect
shed
low
amount
viru
howev
rtrtpcr
identifi
signific
proport
rsvinfect
adult
diagnos
serolog
agreement
falsey
et
al
find
highlight
need
combin
rtrtpcr
serolog
optim
diagnosi
rsv
infect
adult
age
comorbid
appear
influenc
diagnost
sensit
rtrtpcr
serolog
well
known
age
may
influenc
virusspecif
antibodi
respons
serolog
gave
higher
yield
rtrtpcr
detect
rsv
healthi
adult
cap
vs
p
group
significantli
younger
adult
comorbid
median
age
vs
year
p
also
patient
seroconvers
trend
toward
younger
compar
nonserorespond
vs
year
p
addit
presenc
comorbid
show
similar
tendenc
less
frequent
among
serorespond
vs
p
document
underli
diseas
repres
signific
risk
factor
sever
rsv
ill
inabl
develop
sustain
adequ
rsvspecif
neutral
antibodi
respons
could
also
contribut
pathogenesi
diseas
delay
evalu
cap
may
hinder
diagnosi
viral
pathogen
viru
may
longer
present
difficulti
demonstr
seroconvers
acut
convalesc
blood
sampl
falsey
et
al
suggest
young
healthi
individu
may
rapidli
clear
rsv
infect
reduc
viral
shed
period
thu
delay
collect
respiratori
sampl
could
explain
lower
yield
serolog
rsvinfect
adult
without
preexist
condit
nevertheless
studi
delay
sampl
collect
similar
adult
without
comorbid
median
day
p
young
peopl
tend
consult
earlier
adult
year
age
median
day
respect
p
sensit
rtrtpcr
similar
age
group
hand
case
posit
rtrtpcr
serorespond
p
day
symptom
time
sampl
collect
emphas
need
get
specimen
specif
diagnosi
despit
late
consult
case
serolog
identifi
rsv
infect
explan
could
lower
antibodi
titer
acut
phase
sera
could
facilit
detect
seroconvers
howev
mean
antibodi
titer
similar
p
among
case
seroconvers
nonserorespond
addit
neutral
antibodi
titer
compar
patient
rsvposit
rtrtpcr
compar
serorespond
tabl
fact
approxim
adult
document
respiratori
viral
infect
seroconvers
could
partial
explain
absenc
serolog
respons
patient
posit
rtrtpcr
also
place
appropri
rtrtpcr
procedur
qualiti
control
reduc
contamin
reduc
likelihood
falseposit
rtrtpcr
result
low
serumneutr
antibodi
titer
rsv
associ
sever
rsv
diseas
children
adult
studi
serumneutr
antibodi
titer
rsva
rsvb
significantli
lower
rsvinfect
adult
compar
infect
rsva
vs
rsvb
vs
respect
p
likewis
subject
titer
minim
protect
threshold
titer
rsv
hospit
report
piedra
et
al
rsva
b
respect
detect
frequent
adult
rsvrelat
cap
nonrsv
cap
rsva
vs
p
rsvb
vs
p
furthermor
logist
regress
analysi
show
protect
role
higher
level
rsva
rsvbspecif
serumneutr
antibodi
rsvrelat
cap
admiss
icu
thu
rsv
vaccin
increas
neutral
antibodi
titer
reduc
hospit
death
associ
rsvrelat
cap
adult
epidemiolog
rsvrelat
cap
adult
santiago
chile
mirror
month
rsv
outbreak
occur
chile
mainli
may
august
although
major
rsvrelat
cap
adult
occur
rsv
season
mani
case
also
detect
outsid
period
stress
import
consid
rsv
etiolog
even
outbreak
end
conclus
rsv
infect
frequent
adult
cap
santiago
chile
sensit
complementari
methodolog
detect
rsv
includ
laboratori
test
identifi
etiolog
agent
pneumonia
adult
molecular
diagnost
rtrtpcr
one
test
implement
clinic
viral
laboratori
improv
detect
respiratori
viral
pathogen
addit
serolog
assay
especi
microneutr
test
complement
molecular
diagnost
newer
faster
easier
serolog
method
flow
assay
detect
rsvspecif
neutral
antibodi
could
facilit
use
serolog
reliabl
diagnost
method
safe
effect
rsv
vaccin
would
also
benefici
adult
popul
